As of 2025-11-05, the Relative Valuation of Verrica Pharmaceuticals Inc (VRCA) is (96.81) USD. This relative valuation is based on P/E multiples. With the latest stock price at 3.28 USD, the upside of Verrica Pharmaceuticals Inc based on Relative Valuation is -3051.7%.
The range of the Relative Valuation is (94.63) - (100.18) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 17.7x - 19.5x | 18.2x |
| Forward P/E multiples | 18.4x - 21.1x | 19.5x |
| Fair Price | (94.63) - (100.18) | (96.81) |
| Upside | -2985.0% - -3154.4% | -3051.7% |
| Date | P/E |
| 2025-11-04 | -0.64 |
| 2025-11-03 | -0.69 |
| 2025-10-31 | -0.70 |
| 2025-10-30 | -0.69 |
| 2025-10-29 | -0.70 |
| 2025-10-28 | -0.70 |
| 2025-10-27 | -0.73 |
| 2025-10-24 | -0.75 |
| 2025-10-23 | -0.77 |
| 2025-10-22 | -0.76 |
| 2025-10-21 | -0.79 |
| 2025-10-20 | -0.87 |
| 2025-10-17 | -0.81 |
| 2025-10-16 | -0.82 |
| 2025-10-15 | -0.80 |
| 2025-10-14 | -0.80 |
| 2025-10-13 | -0.80 |
| 2025-10-10 | -0.81 |
| 2025-10-09 | -0.84 |
| 2025-10-08 | -0.86 |
| 2025-10-07 | -0.90 |
| 2025-10-06 | -0.91 |
| 2025-10-03 | -0.91 |
| 2025-10-02 | -0.88 |
| 2025-10-01 | -0.86 |
| 2025-09-30 | -0.84 |
| 2025-09-29 | -0.84 |
| 2025-09-26 | -0.81 |
| 2025-09-25 | -0.80 |
| 2025-09-24 | -0.81 |
| 2025-09-23 | -0.84 |
| 2025-09-22 | -0.87 |
| 2025-09-19 | -0.85 |
| 2025-09-18 | -0.79 |
| 2025-09-17 | -0.86 |
| 2025-09-16 | -0.86 |
| 2025-09-15 | -0.96 |
| 2025-09-12 | -0.92 |
| 2025-09-11 | -0.96 |
| 2025-09-10 | -0.98 |
| 2025-09-09 | -0.97 |
| 2025-09-08 | -0.98 |
| 2025-09-05 | -0.99 |
| 2025-09-04 | -1.00 |
| 2025-09-03 | -1.02 |
| 2025-09-02 | -1.04 |
| 2025-08-29 | -1.09 |
| 2025-08-28 | -1.08 |
| 2025-08-27 | -1.10 |
| 2025-08-26 | -1.16 |